Latest Headlines
Should Investors Be Buying Cummins (NYSE:CMI) Stock Following Today’s Standpoint Research Upgrade?
Marie Mckinney
Investors sentiment decreased to 0.9 in Q1 2018. Its down 0.37, from 1.27 in 2017Q4. It dropped, as 70 investors sold Cummins Inc. shares while 284 reduced holdings. 71 funds opened positions while (more…)
- EPS for The Progressive Corporation (PGR) Expected At $0.94
- Lfb Biotechnologies S.A.S.U. Bought More Tg Therapeutics, Inc Shares
- How Will Axis Capital Holdings (NYSE:AXS) Stock React To New Rating Coverage byGoldman Sachs?
- Preferred Bank (PFBC) Analysts See $1.12 EPS
- It is Time to Equal-Weight Eagle Bulk Shipping (EGLE), Morgan Stanley Says. Stock May Be Worth $6.5
- PacWest Bancorp (PACW) EPS Estimated At $0.88
- Standpoint Research Issues a Upgrade for Flex (NASDAQ:FLEX) from a “Hold” to “Buy” Rating
- Arqule Inc: Integrated Core Strategies (Us) Llc Disclosed Stake
- Analysts See $1.31 EPS for Novartis AG (NVS)
- Arthur J. Gallagher (NYSE:AJG) Hit With Buy Rating From Goldman Sachs, Analysts Expect $81 Stock Price
- What’s in Catalyst Biosciences, Inc. (CBIO) After Today’s Huge Decline?
- Gevo, Inc. (GEVO) Increases Again; Strong Momentum for Buyers
- Goldman Sachs Initiates Buy Rating for Everest Re (RE) With a $280.0 Price Target
- EPS for Neogen Corporation (NEOG) Expected At $0.30
- How Analysts Feel About Atossa Genetics Inc. (ATOS) After Making All-Time Low?
Recent Posts
- Should Investors Be Buying Cummins (NYSE:CMI) Stock Following Today’s Standpoint Research Upgrade?
- EPS for The Progressive Corporation (PGR) Expected At $0.94
- Lfb Biotechnologies S.A.S.U. Bought More Tg Therapeutics, Inc Shares
- How Will Axis Capital Holdings (NYSE:AXS) Stock React To New Rating Coverage byGoldman Sachs?
- Preferred Bank (PFBC) Analysts See $1.12 EPS
- It is Time to Equal-Weight Eagle Bulk Shipping (EGLE), Morgan Stanley Says. Stock May Be Worth $6.5
- PacWest Bancorp (PACW) EPS Estimated At $0.88
- Standpoint Research Issues a Upgrade for Flex (NASDAQ:FLEX) from a “Hold” to “Buy” Rating
- Arqule Inc: Integrated Core Strategies (Us) Llc Disclosed Stake
- Analysts See $1.31 EPS for Novartis AG (NVS)
Free Email Newsletter
Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:
© Frisco News and Analysis 2012-2017. All Rights Reserved.
